These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2845305)

  • 1. Cytomegalovirus infection after kidney transplantation using cyclosporin A and low-dose prednisolone immunosuppression.
    Mayer G; Watschinger B; Pohanka E; Graf H; Popow T; Ulrich W; Kovarik J
    Nephrol Dial Transplant; 1988; 3(4):464-8. PubMed ID: 2845305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression.
    Johnson PC; Lewis RM; Golden DL; Oefinger PE; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Jan; 45(1):116-21. PubMed ID: 2827353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin. A prospective study.
    Bosch FH; Hoitsma AJ; Janssen HP; van Loon AM; Koene RA
    Transpl Int; 1989 Aug; 2(2):92-5. PubMed ID: 2551314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
    Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
    Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
    Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
    Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections.
    Kovarik J; Mayer G; Pohanka E; Schwarz M; Traindl O; Graf H; Smolen J
    Transplantation; 1988 Feb; 45(2):402-5. PubMed ID: 2830688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is CMV-hyperimmune serum prophylaxis after kidney transplantation always meaningful?].
    Greger B; Kurth J; Schareck WD; Müller GH; Hopt UT; Bockhorn H
    Immun Infekt; 1985 Sep; 13(5):215-9. PubMed ID: 2998977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
    Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
    Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the incidence and course of CMV infections following kidney transplantation by passive immunization--initial experiences with a hyperimmunoglobulin].
    Hoyer J; Dennin RH; Schulz E
    Immun Infekt; 1985 Nov; 13(6):285-9. PubMed ID: 3000921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
    Shah AP; Chen JM; Fridell JA
    Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
    Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H
    Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence and clinical relevance of cytomegalovirus diseases using cyclosporine compared to conventional immunosuppression].
    Wilms H; Kirste G; Neumann-Häfelin D
    Immun Infekt; 1985 Sep; 13(5):220-3. PubMed ID: 2998978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The problem of cytomegalovirus infection in renal allograft recipients.
    Kurtz JB; Thompson JF; Ting A; Pinto A; Morris PJ
    Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.
    Witzke O; Hauser IA; Bartels M; Wolf G; Wolters H; Nitschke M;
    Transplantation; 2012 Jan; 93(1):61-8. PubMed ID: 22094954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies evaluating high-dose acyclovir, intravenous immune globulin, and cytomegalovirus hyperimmunoglobulin for prophylaxis against cytomegalovirus in kidney transplant recipients.
    Dickinson BI; Gora-Harper ML; McCraney SA; Gosland M
    Ann Pharmacother; 1996 Dec; 30(12):1452-64. PubMed ID: 8968459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation.
    Havel MP; Laczkovics AM; Wolner E; Kurz RW; Popow-Kraupp T
    Clin Ther; 1989; 11(4):472-8. PubMed ID: 2550134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.